CZ347597A3 - Estery karbapenemových sloučenin a farmaceutický prostředek s jejich obsahem - Google Patents

Estery karbapenemových sloučenin a farmaceutický prostředek s jejich obsahem Download PDF

Info

Publication number
CZ347597A3
CZ347597A3 CZ973475A CZ347597A CZ347597A3 CZ 347597 A3 CZ347597 A3 CZ 347597A3 CZ 973475 A CZ973475 A CZ 973475A CZ 347597 A CZ347597 A CZ 347597A CZ 347597 A3 CZ347597 A3 CZ 347597A3
Authority
CZ
Czechia
Prior art keywords
compound
ethyl
methyl
formula
mixture
Prior art date
Application number
CZ973475A
Other languages
Czech (cs)
English (en)
Inventor
George Burton
Stephen Frederick Moss
Alfred John Eglington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508956.1A external-priority patent/GB9508956D0/en
Priority claimed from GBGB9508955.3A external-priority patent/GB9508955D0/en
Priority claimed from GBGB9508957.9A external-priority patent/GB9508957D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CZ347597A3 publication Critical patent/CZ347597A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ973475A 1995-05-03 1996-05-02 Estery karbapenemových sloučenin a farmaceutický prostředek s jejich obsahem CZ347597A3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds

Publications (1)

Publication Number Publication Date
CZ347597A3 true CZ347597A3 (cs) 1998-08-12

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ973475A CZ347597A3 (cs) 1995-05-03 1996-05-02 Estery karbapenemových sloučenin a farmaceutický prostředek s jejich obsahem

Country Status (22)

Country Link
EP (1) EP0823910A1 (fr)
JP (1) JPH11504910A (fr)
KR (1) KR19990008355A (fr)
CN (1) CN1185783A (fr)
AR (1) AR005416A1 (fr)
AU (1) AU5813996A (fr)
BG (1) BG102014A (fr)
BR (1) BR9608313A (fr)
CA (1) CA2217990A1 (fr)
CZ (1) CZ347597A3 (fr)
EA (1) EA199700293A1 (fr)
HU (1) HUP9801066A3 (fr)
IL (1) IL118092A0 (fr)
MA (1) MA23853A1 (fr)
MX (1) MX9708421A (fr)
NO (1) NO974994D0 (fr)
OA (1) OA10632A (fr)
PE (1) PE50697A1 (fr)
PL (1) PL323141A1 (fr)
SK (1) SK146497A3 (fr)
TR (1) TR199701286T1 (fr)
WO (1) WO1996034868A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (fr) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
WO2013157583A1 (fr) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Nouveau composé de carbapénème

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (fr) * 1980-04-30 1986-09-30 Shoji Ikeda Esters d'ampiciline, et leur production
AU7467194A (en) * 1993-08-18 1995-03-14 Sankyo Company Limited Crystalline carbapenem derivatives
KR960705827A (ko) * 1993-10-29 1996-11-08 데이비드 로버츠 2-(피라졸-3-일)카르바페넴 유도체(2-(pyrazol-3-yl)carbapenem derivatives)

Also Published As

Publication number Publication date
NO974994L (no) 1997-10-30
CN1185783A (zh) 1998-06-24
PL323141A1 (en) 1998-03-16
SK146497A3 (en) 1998-05-06
MA23853A1 (fr) 1996-12-31
BG102014A (en) 1998-11-30
HUP9801066A2 (hu) 1998-08-28
BR9608313A (pt) 1999-01-26
OA10632A (en) 2002-09-16
WO1996034868A1 (fr) 1996-11-07
EA199700293A1 (ru) 1998-06-25
CA2217990A1 (fr) 1996-11-07
MX9708421A (es) 1998-02-28
AR005416A1 (es) 1999-06-23
EP0823910A1 (fr) 1998-02-18
IL118092A0 (en) 1996-09-12
HUP9801066A3 (en) 1999-01-28
AU5813996A (en) 1996-11-21
TR199701286T1 (xx) 1998-02-21
NO974994D0 (no) 1997-10-30
JPH11504910A (ja) 1999-05-11
KR19990008355A (ko) 1999-01-25
PE50697A1 (es) 1997-12-18

Similar Documents

Publication Publication Date Title
KR102042867B1 (ko) 베타-락타마제 억제제로서의 헤테로비시클릭 화합물
EP3139918B1 (fr) Acides bêta-tétrazolyle-propioniques utiles en tant qu'inhibiteurs des métallo-bêta-lactamases
EP0272016A1 (fr) Dérivés d'acide pénicillanique 2-bêta-méthyle substitué et leurs sels et esters
US6458780B1 (en) Carbapenem derivatives
US5336674A (en) 2-phenanthridinyl carbaphenem antibacterial agent
SK54095A3 (en) 6-(substituted methylene) penems and intermediates
Azami et al. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems Part IV. 2-Alkyl substituents containing cationic heteroaromatics linked via a C–C bond
EP0760370B1 (fr) Nouveaux derives de carbapeneme
FI89490C (fi) Foerfarande foer framstaellning av 2-metoximetyl-penemderivat
CZ347597A3 (cs) Estery karbapenemových sloučenin a farmaceutický prostředek s jejich obsahem
NZ199487A (en) Azabicycloheptene derivatives,intermediates and pharmaceutical compositions
SK53696A3 (en) Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use
CA2241321A1 (fr) Composes de carbapenem, leur production et leur utilisation
US5328904A (en) 2-phenanthridinyl carbapenem antibacterial agents
JP2708576B2 (ja) カルバペネム誘導体
JPS59196895A (ja) ６−（ヒドロキシアルキル）−２−（ヘテロアリ−ルアルキルチオ）ペネム類、それらの製造方法およびそれらを含む医薬組成物
US5384317A (en) Bridged biphenyl carbapenem compounds, compositions containing such compounds and methods of use
WO2004078119A2 (fr) Thiopohenes substitues a activite antibacterienne
EP0823911A1 (fr) Esters de carbapenemes
JPH09249667A (ja) カルバペネム化合物、その製造法および剤
GB2051046A (en) Penicillanic acid derivatives
MXPA97008421A (en) Carbapene steres
JPH075597B2 (ja) ２−（置換−ジベンゾフラニルおよびジベンゾチエニル）カルバペネム抗菌剤を製造するための中間体
MXPA97008422A (en) Carbapene steres
KR100192740B1 (ko) 항생제 c-3 디티오아세탈-치환 카르바페넴 화합물, 그의 조성물,제조방법 및 용도

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic